709 related articles for article (PubMed ID: 12535959)
21. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
[TBL] [Abstract][Full Text] [Related]
22. Endogenous neurotensin regulates hypothalamic-pituitary-adrenal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus.
Nicot A; Rowe WB; De Kloet ER; Betancur C; Jessop DS; Lightman SL; Quirion R; Rostène W; Bérod A
J Neuroendocrinol; 1997 Apr; 9(4):263-9. PubMed ID: 9147289
[TBL] [Abstract][Full Text] [Related]
23. Expression of corticotropin-releasing hormone type 1 receptor in paraventricular nucleus after acute stress.
Imaki T; Katsumata H; Miyata M; Naruse M; Imaki J; Minami S
Neuroendocrinology; 2001 May; 73(5):293-301. PubMed ID: 11399902
[TBL] [Abstract][Full Text] [Related]
24. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release.
Viau V; Chu A; Soriano L; Dallman MF
J Neurosci; 1999 Aug; 19(15):6684-93. PubMed ID: 10414997
[TBL] [Abstract][Full Text] [Related]
25. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
26. Functional evidence that the nucleus of the hippocampal commissure shows an earlier activation from a stressor than the paraventricular nucleus: Implication of an additional structural component of the avian hypothalamo-pituitary-adrenal axis.
Nagarajan G; Kang SW; Kuenzel WJ
Neurosci Lett; 2017 Mar; 642():14-19. PubMed ID: 28137650
[TBL] [Abstract][Full Text] [Related]
27. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
Ogilvie KM; Lee S; Rivier C
Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
[TBL] [Abstract][Full Text] [Related]
28. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity.
Lee S; Schmidt ED; Tilders FJ; Rivier C
Alcohol Clin Exp Res; 2001 Jan; 25(1):98-105. PubMed ID: 11198721
[TBL] [Abstract][Full Text] [Related]
29. Thyroxine modulates corticotropin-releasing factor but not arginine vasopressin gene expression in the hypothalamic paraventricular nucleus of the developing Rat.
Dakine N; Oliver C; Grino M
J Neuroendocrinol; 2000 Aug; 12(8):774-83. PubMed ID: 10929090
[TBL] [Abstract][Full Text] [Related]
30. Medullary neurones regulate hypothalamic corticotropin-releasing factor cell responses to an emotional stressor.
Dayas CV; Buller KM; Day TA
Neuroscience; 2001; 105(3):707-19. PubMed ID: 11516835
[TBL] [Abstract][Full Text] [Related]
31. Diurnal corticotropin-releasing hormone mRNA variation in the hypothalamus exhibits a rhythm distinct from that of plasma corticosterone.
Kwak SP; Young EA; Morano I; Watson SJ; Akil H
Neuroendocrinology; 1992 Jan; 55(1):74-83. PubMed ID: 1319007
[TBL] [Abstract][Full Text] [Related]
32. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.
Mantsch JR; Taves S; Khan T; Katz ES; Sajan T; Tang LC; Cullinan WE; Ziegler DR
Neurosci Lett; 2007 Mar; 415(3):269-73. PubMed ID: 17293045
[TBL] [Abstract][Full Text] [Related]
33. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
Stewart LQ; Roper JA; Young WS; O'Carroll AM; Lolait SJ
Psychoneuroendocrinology; 2008 May; 33(4):405-15. PubMed ID: 18243568
[TBL] [Abstract][Full Text] [Related]
34. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus.
Makino S; Gold PW; Schulkin J
Brain Res; 1994 Mar; 640(1-2):105-12. PubMed ID: 8004437
[TBL] [Abstract][Full Text] [Related]
35. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
Naert G; Ixart G; Tapia-Arancibia L; Givalois L
Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
[TBL] [Abstract][Full Text] [Related]
36. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids.
Luo X; Kiss A; Rabadan-Diehl C; Aguilera G
Endocrinology; 1995 Sep; 136(9):3877-83. PubMed ID: 7649095
[TBL] [Abstract][Full Text] [Related]
37. Stress and interleukin-1 beta-induced activation of c-fos, NGFI-B and CRF gene expression in the hypothalamic PVN: comparison between Sprague-Dawley, Fisher-344 and Lewis rats.
Rivest S; Rivier C
J Neuroendocrinol; 1994 Feb; 6(1):101-17. PubMed ID: 8025563
[TBL] [Abstract][Full Text] [Related]
38. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress.
Shepard JD; Barron KW; Myers DA
Brain Res; 2003 Feb; 963(1-2):203-13. PubMed ID: 12560126
[TBL] [Abstract][Full Text] [Related]
39. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
Parsadaniantz SM; Batsché E; Gegout-Pottie P; Terlain B; Gillet P; Netter P; Kerdelhué B
Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
[TBL] [Abstract][Full Text] [Related]
40. Prolonged alcohol intake leads to reversible depression of corticotropin-releasing hormone and vasopressin immunoreactivity and mRNA levels in the parvocellular neurons of the paraventricular nucleus.
Silva SM; Paula-Barbosa MM; Madeira MD
Brain Res; 2002 Nov; 954(1):82-93. PubMed ID: 12393236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
